Cargando…

Pre-hospital antiplatelet medication use on COVID-19 disease severity

OBJECTIVE: To evaluate the association between pre-hospitalization antiplatelet medication use and COVID-19 disease severity. DESIGN: Retrospective cohort study. SETTING: Inpatient units at The Mount Sinai Hospital. PATIENTS: Adults age ≥18 admitted between March 1, 2020 and April 9, 2020 with confi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Darren, Ip, Ada, Zhan, Serena, Wasserman, Isaac, Snyder, Daniel J., Agathis, Alexandra Z., Shamapant, Nikhil, Yang, Jeong Yun, Pai, Akila, Mazumdar, Madhu, Poor, Hooman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156906/ https://www.ncbi.nlm.nih.gov/pubmed/34090177 http://dx.doi.org/10.1016/j.hrtlng.2021.04.010

Ejemplares similares

Platelets: Pathophysiology and Antiplatelet Drug Therapy
por: Snyder, Edward L.
Publicado: (1983)

Is preoperative anemia a significant risk factor for splenectomy patients? A NSQIP analysis
por: Agathis, Alexandra Z., et al.
Publicado: (2020)

Successful Treatment of Refractory Massive Pulmonary Embolism with Repeated Administration of Systemic Thrombolysis
por: Poor, Armeen D., et al.
Publicado: (2018)

Pulmonary Thrombosis and Thromboembolism in COVID-19
por: Poor, Hooman D.
Publicado: (2021)

The Influence of Increasing Levels of Provider-Patient Discussion on Quit Behavior: An Instrumental Variable Analysis of a National Survey
por: Liu, Bian, et al.
Publicado: (2021)

Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”
por: Nadeem, Arsalan, et al.
Publicado: (2022)

Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”
por: Dhakal, Sandesh
Publicado: (2023)

Personalized antiplatelet therapy: state of the art
por: Gurbel, Paul A, et al.
Publicado: (2012)

The Effect of Pre-operative use of Antiplatelets and Anticoagulants on Time to Surgery in Hip Fracture Patients
por: Shamsuri, NS, et al.
Publicado: (2023)

Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002)

Precision antiplatelet therapy
por: Rocca, Bianca, et al.
Publicado: (2023)

Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients
por: Ho, Gwendolyn, et al.
Publicado: (2020)

Examining annual transitions in healthcare spending among U.S. medicare beneficiaries using multistate Markov models: Analysis of medicare current beneficiary survey data, 2003–2019
por: Li, Lihua, et al.
Publicado: (2023)

The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan
por: Togano, Tomiteru, et al.
Publicado: (2021)

Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
por: Jung, Jung Hwa, et al.
Publicado: (2015)

Biomarkers and Right Ventricular Dysfunction
por: Pradhan, Natasha M., et al.
Publicado: (2020)

Antiplatelet therapy and the vascular tree
por: Blann, A
Publicado: (2006)

Antiplatelets in Secondary Stroke Prevention
por: Shulga, Olga, et al.
Publicado: (2011)

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Antiplatelet Drugs and Endothelial Function
por: Higashi, Yukihito
Publicado: (2016)

Antitcoagulant and antiplatelet activities of scolymoside
por: Yoon, Eun-Kyung, et al.
Publicado: (2015)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Effect of Catechol Content in Catechol-Conjugated Dextrans on Antiplatelet Performance
por: Jeong, Yeonwoo, et al.
Publicado: (2017)

Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients
por: Ho, Gwendolyn, et al.
Publicado: (2021)

Discharge prescription patterns for antiplatelet and statin therapy following carotid endarterectomy: an analysis of the vascular quality initiative
por: Eppler, Michael, et al.
Publicado: (2023)

Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Combined Antiplatelet Therapy Reduces the Proinflammatory Properties of Activated Platelets
por: Heinzmann, Alexandra C.A., et al.
Publicado: (2021)

Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage
por: Li, Yunjie, et al.
Publicado: (2023)

Hyponatremia due to Severe Primary Hypothyroidism in an Infant
por: Agathis, Nickolas T., et al.
Publicado: (2015)

Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation
por: Park, Yongwhi, et al.
Publicado: (2017)

Prevalence of antiplatelet therapy in patients with diabetes
por: Miller, Shaun R, et al.
Publicado: (2005)

Antiplatelet combinations for prevention of atherothrombotic events
por: Bollati, Mario, et al.
Publicado: (2011)

Antiplatelet Therapy for Every Diabetic Person?
por: Nicolucci, Antonio, et al.
Publicado: (2011)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Thrombin Receptor Antagonism in Antiplatelet Therapy
por: Olivier, C., et al.
Publicado: (2013)

Patterns of antiplatelet agent use in the US
por: Kanakadandi, Vijay, et al.
Publicado: (2015)

Anticoagulant Activities of Indobufen, an Antiplatelet Drug
por: Liu, Jia, et al.
Publicado: (2018)

Antiplatelet therapy and bladder tumor resection
por: Goel, Apul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d8qoj0j4urkgiaflnf7355s3pg